Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dragon Gate Investment Partners is a private investment and advisory firm based in New York City. Public descriptions characterize it as a for-profit financial services business focused on investment, advisory, investor relations, and market-intelligence style support, with an emphasis on helping companies operate across the U.S. and China. The firm has also described a thematic focus on space-related technology and art, rather than drug development or healthcare operations. While it has worked with at least one healthcare company as a financial advisor, it does not appear to be a life sciences developer, pharmaceutical company, or healthcare operating company. For biotech analyst purposes, Dragon Gate Investment Partners is best understood as a finance/advisory counterparty rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dragon Gate Investment Partners.